Progyny, Inc. Shareholders Equity (Tangible)

Shareholders Equity (Tangible) of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shareholders Equity (Tangible) growth rates and interactive chart.


Highlights and Quick Summary

  • Shareholders Equity (Tangible) for the quarter ending September 29, 2021 was $212 Million (a 10.27% increase compared to previous quarter)
  • Year-over-year quarterly Shareholders Equity (Tangible) increased by 37.47%
  • Annual Shareholders Equity (Tangible) for 2020 was $154 Million (a 53.83% increase from previous year)
  • Annual Shareholders Equity (Tangible) for 2019 was $100 Million (a -190.22% decrease from previous year)
  • Annual Shareholders Equity (Tangible) for 2018 was $-111 Million (a -3.47% decrease from previous year)
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shareholders Equity (Tangible) of Progyny, Inc.

Most recent Shareholders Equity (Tangible)of PGNY including historical data for past 10 years.

Interactive Chart of Shareholders Equity (Tangible) of Progyny, Inc.

Progyny, Inc. Shareholders Equity (Tangible) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $211.51 $191.81 $171.77
2020 $153.85 $113.91 $105.93 $107.18 $153.85
2019 $100.02 $-105.88 $-104.51 $100.02
2018 $-110.85 $-110.85
2017 $-114.84 $-114.84

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.